Literature DB >> 15821545

Sexual function in women with pelvic organ prolapse compared to women without pelvic organ prolapse.

Joseph M Novi1, Stacey Jeronis, Mark A Morgan, Lily A Arya.   

Abstract

PURPOSE: We compared sexual function in women with pelvic organ prolapse to that in women without prolapse.
MATERIALS AND METHODS: We collected sexual function data using a standardized, validated, condition specific questionnaire. The study group consisted of 30 women with pelvic organ prolapse and it was compared with 30 unmatched controls without evidence of prolapse.
RESULTS: The 2 groups were similar in age, race, parity and postmenopausal hormone use. Subjects in the study group were more likely to have undergone previous pelvic surgery. Mean total Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire scores +/- SD were lower in the study group compared with controls (81.4 +/- 7.3 vs 106.4 +/- 15.5, p <0.001). In the study group total questionnaire scores in women with prior pelvic surgery were similar to those in women without prior pelvic surgery (79.3 +/- 14.9 vs 82.9 +/- 10.2, p = 0.61).
CONCLUSIONS: Pelvic organ prolapse appears to have a significant negative impact on sexual function.

Entities:  

Mesh:

Year:  2005        PMID: 15821545     DOI: 10.1097/01.ju.0000154618.40300.c8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  27 in total

1.  Significance of preoperative calculation of uterine weight as an indicator for preserving the uterus in pelvic reconstructive surgery.

Authors:  Qingsong Sheng; Ning Ma; Huijuan Huang; Bo Xu; Chunni He; Yanfeng Song
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

2.  Recurrent urinary tract infections in women with symptoms of pelvic floor dysfunction.

Authors:  Bernard T Haylen; Joseph Lee; Sue Husselbee; Matthew Law; Jialun Zhou
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-03-17

3.  Female sexual dysfunction: are urogynecologists ready for it?

Authors:  Anne-Marie Roos; Ranee Thakar; Abdul H Sultan; Inka Scheer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-10-14

4.  The Portuguese validation of the short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12).

Authors:  Gulnara Waleska Rubio Martinez Santana; Tsutomu Aoki; Antonio Pedro Flores Auge
Journal:  Int Urogynecol J       Date:  2011-07-28       Impact factor: 2.894

5.  Sexual function in older women with pelvic floor symptoms: a cross-sectional study in general practice.

Authors:  Chantal McR Panman; Marian Wiegersma; Marrit N Talsma; Boudewijn J Kollen; Marjolein Y Berger; Yvonne Lisman-Van Leeuwen; Janny H Dekker
Journal:  Br J Gen Pract       Date:  2014-03       Impact factor: 5.386

6.  Sexual function in women after rectocele repair with acellular porcine dermis graft vs site-specific rectovaginal fascia repair.

Authors:  Joseph M Novi; Catherine S Bradley; Najjia N Mahmoud; Mark A Morgan; Lily A Arya
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-01-11

7.  Correlation of pelvic organ prolapse staging with lower urinary tract symptoms, sexual dysfunction, and quality of life.

Authors:  Serife Esra Cetinkaya; Fulya Dokmeci; Omer Dai
Journal:  Int Urogynecol J       Date:  2013-03-28       Impact factor: 2.894

Review 8.  Assessment of sexual function in women with pelvic floor dysfunction.

Authors:  Dorothy Kammerer-Doak
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05

Review 9.  Review of current status of female sexual dysfunction evaluation in urogynecology.

Authors:  Ranee Thakar
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05

10.  Sexual activity and function in women with and without pelvic floor disorders.

Authors:  Tola B Omotosho Fashokun; Heidi S Harvie; Megan O Schimpf; Cedric K Olivera; Lee B Epstein; Marjorie Jean-Michel; Kristin E Rooney; Sunil Balgobin; Okechukwu A Ibeanu; Rajiv B Gala; Rebecca G Rogers
Journal:  Int Urogynecol J       Date:  2012-06-29       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.